The forecast for the R&D budget in Health and Medical Sciences in Chile shows a steady decline from 2024 to 2028. The values begin at 92.92 million USD PPP in 2024 and decrease yearly, reaching 87.08 million USD PPP by 2028. For context, the value stood at 94 million USD PPP in 2023.
The year-on-year variations show a decreasing trend:
- From 2024 to 2025: -1.58%
- From 2025 to 2026: -1.61%
- From 2026 to 2027: -1.62%
- From 2027 to 2028: -1.63%
The Compound Annual Growth Rate (CAGR) over the five-year period from 2024 to 2028 is -1.58%, indicating a consistent average annual decline.
Future Trends to Watch For:
As the R&D budget in Health and Medical Sciences in Chile is forecasted to decline, stakeholders should monitor government policy shifts and economic factors that might affect funding. Particular attention should be paid to how global economic conditions and local healthcare demands might necessitate adjustments in R&D spending. Additionally, innovations in healthcare technology and external funding sources such as international grants or private investments could potentially influence future budgets positively.
